The University of Chicago Header Logo
Last Name


Michael H. Davidson to Clinical Trials, Phase I as Topic

This is a "connection" page, showing publications Michael H. Davidson has written about Clinical Trials, Phase I as Topic.

Connection Strength
  1. Davidson MH. Emerging low-density lipoprotein therapies: Targeting PCSK9 for low-density lipoprotein reduction. J Clin Lipidol. 2013 May-Jun; 7(3 Suppl):S11-5.
    View in: PubMed
    Score: 0.115
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.